5 insiders bought €696k of shares over the last 90 days, the latest by Sanja Batljan, filed 22 Oct 2026.
Cluster: 5 buyers in 30 daysEpisurf Medical AB is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. 11 insiders have disclosed 27 filings since 23 October 2025.
On the market, 6 insiders bought (7 purchases totalling €1.2M) while 2 insiders sold (5 sales totalling €30.8M). Sales outweigh purchases by €29.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a sale of €19.6M from Ilija BATLJAN, disclosed on 21 October 2026. On the buying side, the filings list 3 board members, 2 chief executives and 1 finance chief among the declarants.
With 27 filings in twelve months, the company is more active than the median of 9 filings across the 1,029 companies we follow on the same exchange. The full history, which starts in 2017, counts 124 purchases against 16 sales.
The clock since the last published purchase (22 October 2026) now reads 2 days. The median gap between a trade and its publication by Finansinspektionen is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades.
Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
+3 other insiders
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 255 declarations
Episurf Medical AB is a company focused on developing medical solutions for joint injuries. It concentrates on innovative treatments to enhance patients' quality of life.
Insider filings
Over the last 90 days, 1 filing published on 19 October 2026: 1 open-market purchase by insiders for €2,236. Largest amounts: Ilija BATLJAN (Styrelseledamot), purchases of €2,236.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 23 October 2026 (UTC)